Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

WASHINGTON, DC—Coronary stent infections are highly fatal and represent an understudied complication following PCI, a new analysis highlights. “Several important questions about coronary stent ...

There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...

More than a fifth of all coronary stents given to Medicare patients at hospitals nationwide from 2019 to 2021 are medically unnecessary, driving more than $2.4 billion in unnecessary program spending ...

SAN ANTONIO. -- CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel ...

On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...

Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B 6 ...

The medical literature contains a huge number of studies on the safety and performance of novel stent platforms, with primary outcomes usually assessed at 6 months or 1 year. The 5-year analysis from ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...

Cardiologists are speaking out against a Lown Institute report that alleged 1 in 5 stents placed in Medicare recipients were considered “overuse,” Medscape reported Dec. 20. The October report looked ...

A new report published Tuesday found over one in five coronary stents placed between 2019 and 2021 were unnecessary, costing Medicare $800 million a year and putting patients at risk of complications ...